{"id":"NCT00755040","sponsor":"Vanderbilt-Ingram Cancer Center","briefTitle":"Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder","officialTitle":"Randomized Placebo Controlled Double Blind Study of Restasis Versus Placebo in Primary Prevention of Ocular GVHD After Allogeneic Stem Cell Transplantation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-10","primaryCompletion":"2014-12","completion":"2016-05","firstPosted":"2008-09-18","resultsPosted":"2016-12-08","lastUpdate":"2017-03-07"},"enrollment":164,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Chronic Myeloproliferative Disorders","Graft Versus Host Disease","Leukemia","Lymphoma","Multiple Myeloma and Plasma Cell Neoplasm","Myelodysplastic Syndromes","Myelodysplastic/Myeloproliferative Neoplasms"],"interventions":[{"type":"DRUG","name":"cyclosporine ophthalmic emulsion","otherNames":[]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Ocular Cyclosporine (Restasis)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"RATIONALE: Cyclosporine eye drops may prevent graft-versus-host disease of the eye in patients who have undergone donor stem cell transplant for hematologic cancer or bone marrow failure disorder.\n\nPURPOSE: This randomized phase I trial is studying how well cyclosporine eye drops work in preventing graft-versus-host disease of the eye in patients who have undergone donor stem cell transplant for hematologic cancer or bone marrow failure disorder.","primaryOutcome":{"measure":"Number of Patients That Develop Ocular GVHD While on Study in the Two Arms (Ocular Cyclosporine (Restasis) vs. Placebo)","timeFrame":"Up to 2 years after transplantation","effectByArm":[{"arm":"Arm I","deltaMin":9,"sd":null},{"arm":"Arm II","deltaMin":8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":">0.99"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":["22157574"],"seeAlso":["http://www.vicc.org/ct/"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":83},"commonTop":["Burning","Red eye","Visual disturbance","Excessive tearing","Itching"]}}